SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001583648-22-000019
Filing Date
2022-04-29
Accepted
2022-04-29 16:06:25
Documents
7
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A pirs2022proxystatement.htm DEF 14A 591408
2 a2019proximage1a07.jpg GRAPHIC 19022
3 a2019proximage2a07.gif GRAPHIC 2673
4 amosignature.jpg GRAPHIC 8366
5 headerlogojpa.jpg GRAPHIC 7676
6 pierispharmaceuticalsinc_v.jpg GRAPHIC 481464
7 pierispharmaceuticalsinc_va.jpg GRAPHIC 277405
  Complete submission text file 0001583648-22-000019.txt   1689539
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37471 | Film No.: 22875206
SIC: 2834 Pharmaceutical Preparations